Direct supplementation with Urolithin A overcomes limitations of dietary exposure and gut microbiome variability in healthy adults to achieve consistent levels across the population.

Singh, Anurag; D'Amico, Davide; Andreux, Pénélope A; Dunngalvin, Gillian; Kern, Timo; Blanco-Bose, William; Auwerx, Johan; Aebischer, Patrick; Rinsch, Chris

Singh, Anurag; D'Amico, Davide; Andreux, Pénélope A; Dunngalvin, Gillian; Kern, Timo; Blanco-Bose, William; Auwerx, Johan; Aebischer, Patrick; Rinsch, Chris.

Afiliação

Singh A; Amazentis SA, EPFL Innovation Park, Lausanne, Switzerland. contact@amazentis.com.
D'Amico D; Amazentis SA, EPFL Innovation Park, Lausanne, Switzerland.
Andreux PA; Amazentis SA, EPFL Innovation Park, Lausanne, Switzerland.
Dunngalvin G; Atlantia Food Clinical Trials, Cork, Ireland.
Kern T; Clinical Microbiomics, København, Denmark.
Blanco-Bose W; Amazentis SA, EPFL Innovation Park, Lausanne, Switzerland.
Auwerx J; Laboratory of Integrative Systems Physiology, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Aebischer P; Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Rinsch C; Amazentis SA, EPFL Innovation Park, Lausanne, Switzerland.

Eur J Clin Nutr ; 76(2): 297-308, 2022 02.

Article em En | MEDLINE | ID: mdl-34117375

Assuntos

Microbioma Gastrointestinal; Adulto; Cumarínicos/farmacologia; Exposição Dietética; Suplementos Nutricionais; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Microbioma Gastrointestinal Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google